Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BY-NCPharmacoepidemiology and drug safety

Temporal Trends in Patient Characteristics, Anticoagulation Treatment Quality, and Clinical Outcomes of Individuals Receiving Vitamin K Antagonists in the Netherlands (2014 Until–2022)

  1. 1Leiden University Medical Center
  2. 2Erasmus University Medical Center

Related

  1. Medication adherence and treatment persistence following switching from vitamin K antagonists to direct oral anticoagulants: a systematic review.
    Ahmed Alaqab, Mohammed Alfaqeeh, Rosnani Hashim +5
    BMC cardiovascular disordersPeer-reviewedCC BYFull text1 citedCardiovascular medicineEurope PMCPMC
  2. Comparison of Neurophysiological Characteristics Using Heart Rate Variability Between Patients With Korean Hwa-byung and Healthy Individuals
    Sun-Woo Chung, Ki-Hwan Yook, Chun Il Park +3
    Psychiatry investigationPeer-reviewedCC BY-NCFull textEurope PMC
  3. Mental Health Treatment Preferences of Individuals Incarcerated at a Women’s Prison
    Talia R. Cohen, Valerie Nguyen, Michael Koenigs
    PsyArXivPreprintAll rights reservedFull textPsychiatry & mental healthOSF
  4. Impact of opioid agonist therapies on non-fatal and fatal overdose: treatment patterns among individuals with opioid use disorder in Ontario, Canada
    Kenneth Lee, Vincent Lam, Jennifer Nicolle +4
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Association of small nerve fiber dysfunction on pain characteristics in type 2 diabetes mellitus individuals with chronic low back pain
    Shetty Shrija Jaya, Shyamasunder Bhat N, Rajagopal Kadavigere +4
    Scientific ReportsPeer-reviewedCC BYFull textPhysiologyDOAJ
BibTeX
@article{zielinski2026temporal,
  title = {{Temporal Trends in Patient Characteristics, Anticoagulation Treatment Quality, and Clinical Outcomes of Individuals Receiving Vitamin K Antagonists in the Netherlands (2014 Until–2022)}},
  author = {Gilda D. Zielinski and Qingui Chen and Marieke J. H. A. Kruip and Frederikus A. Klok and Suzanne C. Cannegieter and Nienke van Rein},
  journal = {Pharmacoepidemiology and drug safety},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655355},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Temporal Trends in Patient Characteristics, Anticoagulation Treatment Quality, and Clinical Outcomes of Individuals Receiving Vitamin K Antagonists in the Netherlands (2014 Until–2022)
AU  - Gilda D. Zielinski
AU  - Qingui Chen
AU  - Marieke J. H. A. Kruip
AU  - Frederikus A. Klok
AU  - Suzanne C. Cannegieter
AU  - Nienke van Rein
PY  - 2026
DA  - 2026/10/01
JO  - Pharmacoepidemiology and drug safety
UR  - https://europepmc.org/article/PMC/PMC13655355
SN  - 1053-8569
SN  - 1099-1557
ER  -